Related by context. Frequent words. (Click for all words.) 82 cutaneous T cell 76 lymphoma CTCL 72 forodesine 72 relapsed refractory multiple myeloma 71 romidepsin 71 gastrointestinal stromal tumors GIST 70 subcutaneous formulation 70 Initiate Phase 70 Acute Myeloid Leukemia AML 69 multiple myeloma MM 69 Panzem R 69 luteinizing hormone releasing 69 refractory peripheral T 69 Pivotal Phase III 69 relapsed multiple myeloma 69 Amrubicin 68 leukemia CLL 68 liposomal formulation 68 Recombinant Human 68 ISTODAX 68 anticancer compound 68 proteasome inhibitor 68 fumarate 68 Epratuzumab 68 Voreloxin 68 Clevudine 67 Traficet EN 67 gastrointestinal stromal tumors 67 C1 esterase inhibitor 67 carcinoid syndrome 67 phase IIb clinical 67 Irinotecan 67 Pegasys ® 67 multi kinase inhibitor 67 Pivotal Phase 67 hepatitis C HCV 67 AA amyloidosis 67 oropharyngeal candidiasis 67 R sorafenib tablets 67 myelodysplastic syndrome MDS 67 mTOR inhibitor 67 MKC# 67 MEK inhibitor 66 refractory Hodgkin lymphoma 66 metastatic castration resistant 66 Chronic Idiopathic Constipation 66 Alemtuzumab 66 Belimumab 66 superficial bladder cancer 66 Factor VIIa 66 Ixempra 66 HER2 positive metastatic breast 66 non alcoholic steatohepatitis 66 leukemia ALL 66 acute myelogenous leukemia AML 66 Metastatic Melanoma 66 VALSTAR 66 metastatic renal cell carcinoma 66 thymalfasin 66 PEG SN# 66 Gemzar ® 65 metastatic hormone refractory 65 primary hypercholesterolemia 65 Vandetanib 65 CD# expressing 65 recurrent glioblastoma 65 factor G CSF 65 Lenalidomide 65 Application MAA 65 Orphan Drug status 65 diabetic neuropathic pain 65 Nexavar ® 65 Completes Enrollment 65 chemotherapy induced neutropenia 65 Zolinza 65 Azedra 65 opioid induced constipation 65 BAY #-# 65 imatinib mesylate 65 Cetrorelix 65 refractory multiple myeloma 65 secondary hyperparathyroidism 65 immunomodulator 65 follicular non 65 plus gemcitabine 64 lupus nephritis 64 pseudobulbar affect PBA 64 advanced carcinoid 64 injection USP 64 angiogenesis inhibitor 64 Fludara 64 Diabetic Macular Edema 64 androgen independent 64 registrational trial 64 Icatibant 64 Pivotal Trial 64 Rebif ® 64 chronic lymphocytic leukemia CLL 64 calcineurin inhibitors 64 pheochromocytoma 64 glioblastoma multiforme GBM